The FDA maintains the boxed warning because proving a negative, proving that something definitively does NOT cause cancer, requires decades of surveillance data
In 2023, Richards and his colleagues published a comparison between patients taking semaglutide and those using lisdexamfetamine and topiramate, a combination medication already approved for binge eating or weight loss
NAFLD in lean individuals: not a benign disease
This could provide another significant treatment option for patients living with diabetes or obesity, Ali says
This means your contraceptive dose and efficacy remain stable when combining these treatments
Kennedy, S., Bergqvist, A., Chapron, C., DHooghe, T., Dunselman, G., Greb, R., & ESHRE Special Interest Group for Endometriosis and Endometrium Guideline Development Group